STAR Sports Medicine

, provides arthroscopic sports medicine solutions for the healthcare industry. The company utilizes technology platforms such as biomaterials, imaging power, smart medical, and tissue engineering to develop its products. The company’s portfolio includes 63 products, including implants, surgical equipment, and regenerative repair products, supported by numerous domestic and international medical device certificates. Prior to going public, the company completed two deals. The company works with hospitals and surgical centers to provide advanced shoulder implants, surgical instruments, and full-cycle clinical sports medicine solutions. The products facilitate minimally invasive surgical procedures for soft tissue injuries across the shoulder, knee, hip, foot, ankle, elbow, hand, and wrist. The company generates revenue from B2B contracts with healthcare providers globally. Sales involve surgical instruments and implants tailored to specific surgical needs.

1. Series B

   Jan 1, 2022

   Amount

   Undisclosed

   Investors

   Locked

2. Angel

   Jul 22, 2020

   Amount

   Undisclosed

   Investors

   Locked